Focus on Women's and Men's Health

SurePath vs ThinPrep: New National Screening Data on Comparative Performance for Cervical Disease Detection

April 28, 201533 min
Host: Thomas C. Wright, Jr., MD

During the EUROGIN 2015 congress held in Sevilla, Spain, a panel was convened to discuss the performance of SurePath™ and ThinPrep® liquid-based cytology methods in the detection of cervical disease, and how these results impact clinical practice. Moderating the panel was Dr. Thomas C. Wright, Jr, Professor Emeritus of Pathology and Cell Biology at the Columbia University Medical Center. Dr. Wright was joined by the following expert panelists: Jesper Bonde, PhD – Senior Researcher, Molecular Pathology Lab Department of Pathology, Hvidovre Hospital, Hvidovre, Denmark Mina Desai, MSc, PhD – Editor in Chief, Cytopathology (2015), Head of the Service, Manchester Cytology Center (retired), Director, Northwest Cytology Training Center (retired), Past President, British Society For Clinical Cytology, Manchester, England Warner K. Huh, MD – Professor, Margaret Cameron Spain Endowed Chair in Obstetrics/Gynecology, University of Alabama in Birmingham, Birmi

Chat About SurePath vs ThinPrep: New National Screening Data on Comparative Performance for Cervical Disease Detection

For You